CHAMPION PCI
- 8,877 participants
- 6 sites in New Zealand
- 268 sites in 14 countries
CHAMPION – Cangrelor for High Risk Advanced Modern Percutaneous InterventiON
This is a phase III clinical trial comparing cangrelor (study medication) to clopidogrel (standard treatment) in participants who require percutaneous coronary intervention (with or without stent). The purpose of this trial is to compare the effects of cangrelor with the standard treatment, clopidogrel.